Soraya Medina Delpino
Family · Hialeah, FLNPI 1679068936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,429 of the $7,954 with a category attached, or 68.3%. 26 manufacturers reported payments, led by Boehringer Ingelheim at 41.8% of the total. Reporting peaked in 2023 at $3,906 and has fallen 55.2% since, to $1,751 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $43.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3K
- AstraZeneca$1K
- Lilly USA, LLC$580
- Amgen$526
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$305
- GSK$269
- plus $2K from 20 others
What the payments were for
- Travel & lodging$2,52532%
- Food & beverage$5,42968%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 18 | $3,324 |
| AstraZeneca | 28 | $1,126 |
| Lilly USA, LLC | 17 | $580 |
| Amgen | 18 | $526 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $305 |
| GSK | 9 | $269 |
| Novartis | 12 | $248 |
| Novo Nordisk | 7 | $221 |
| Johnson & Johnson(2 entities) | 12 | $219 |
| Eisai Inc. | 3 | $185 |
| Kowa Pharmaceuticals America, Inc. | 5 | $182 |
| Sanofi-aventis U.S. LLC | 7 | $136 |
| Paratek Pharmaceuticals, Inc. | 5 | $86 |
| Pfizer | 4 | $83 |
| Exact Sciences | 3 | $73 |
| Amarin Pharma, Inc. | 4 | $69 |
| AbbVie | 3 | $64 |
| Merck | 3 | $58 |
| Insmed, Inc. | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $32 |
| Redhill Biopharma Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Gilead | 1 | $21 |
| Amphastar Pharmaceuticals, Inc. | 1 | $20 |
| Myovant Sciences Inc. | 1 | $18 |
| Bayer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,954 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Temazepam | 30 | $189 |
| Metoprolol Succinate | 13 | $175 |
| Atorvastatin Calcium | 15 | $142 |
Paid to pharmacies, not to this prescriber.
Other family in Hialeah
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.